Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Cytomegalovirus Infection

Free Subscription Articles published in Transplant Proc Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

July 2018
1. KOMOROWSKA-JAGIELSKA K, Heleniak Z, Debska-Slizien A
   Cytomegalovirus Status of Kidney Transplant Recipients and Cardiovascular Risk.
   Transplant Proc. 2018;50:1868-1873.
   PubMed     Text format     Abstract available
   
   
   June 2018
2. HWANG SD, Lee JH, Lee SW, Kim JK, et al
   Effect of Low-Dose Vs Standard-Dose Valganciclovir in the Prevention of Cytomegalovirus Disease in Kidney Transplantation Recipients: A Systemic Review and Meta-Analysis.
   Transplant Proc. 2018 Jun 2. pii: S0041-1345(18)30067.
   PubMed     Text format     Abstract available
   
   
   
3. BODRO M, Sanclemente G, Crespo G, Linares L, et al
   Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
   Transplant Proc. 2018;50:1437-1443.
   PubMed     Text format     Abstract available
   
   
   
4. LEE H, Lee S, Jeon JS, Kwon SH, et al
   Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
   Transplant Proc. 2018;50:1285-1288.
   PubMed     Text format     Abstract available
   
   
   May 2018
5. PARK WY, Kang SS, Jin K, Park SB, et al
   Is the Clinical Outcome Good or Bad in Patients Hospitalized Within 1 Year After Kidney Transplantation?
   Transplant Proc. 2018;50:1001-1004.
   PubMed     Text format     Abstract available
   
   
   April 2018
6. LEE JH, Hwang SD, Song JH, Kim JH, et al
   Efficacy of Ultralow-Dose Valganciclovir Chemoprophylaxis for Cytomegalovirus Infection in ABO-Incompatible Kidney Transplantation Recipients.
   Transplant Proc. 2018 Apr 11. pii: S0041-1345(18)30575.
   PubMed     Text format     Abstract available
   
   
   
7. NANMOKU K, Shinzato T, Kubo T, Shimizu T, et al
   Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus.
   Transplant Proc. 2018 Apr 6. pii: S0041-1345(18)30096.
   PubMed     Text format     Abstract available
   
   
   
8. BOND MMK, Bond MMK, Sehn A, Dias VH, et al
   Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation?
   Transplant Proc. 2018;50:809-814.
   PubMed     Text format     Abstract available
   
   
   March 2018
9. DE GRACIA-GUINDO MDC, Ruiz-Fuentes MDC, Galindo-Sacristan P, Osorio-Moratalla JM, et al
   Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation.
   Transplant Proc. 2018;50:578-580.
   PubMed     Text format     Abstract available
   
   
   
10. CINTRA-CABRERA M, Suarez-Benjumea A, Bernal-Blanco G, Gonzalez-Roncero FM, et al
    Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
    Transplant Proc. 2018;50:575-577.
    PubMed     Text format     Abstract available
    
    
    January 2018
11. BARADHI KM, Aure RL, El-Amm JM
    High-dose Valganciclovir Treatment for Resistant Cytomegalovirus Colitis due to UL97 and UL54 Mutations.
    Transplant Proc. 2018;50:142-144.
    PubMed     Text format     Abstract available
    
    
    
12. NANMOKU K, Shinzato T, Kubo T, Shimizu T, et al
    Prevention of Late-Onset Cytomegalovirus Infection and Disease in Donor-Positive/Recipient-Negative Kidney Transplant Recipients Using Low-Dose Valganciclovir.
    Transplant Proc. 2018;50:124-129.
    PubMed     Text format     Abstract available
    
    
    December 2017
13. HALLECK F, Khadzhynov D, Schrezenmeier E, Lehner L, et al
    Prolonged Low-Dose Prophylaxis With Valganciclovir in Cytomegalovirus-Negative Recipients of Kidney Transplants From Cytomegalovirus-Positive Donors Allows Seroconversion and Prevents Cytomegalovirus Disease.
    Transplant Proc. 2017;49:2280-2284.
    PubMed     Text format     Abstract available
    
    
    October 2017
14. KAYA AH, Tekgunduz E, Akpinar S, Batgi H, et al
    Is Cytomegalovirus Surveillance Necessary for Patients With Low Reactivation Risk in an Autologous Hematopoietic Cell Transplantation Setting?
    Transplant Proc. 2017;49:1911-1915.
    PubMed     Text format     Abstract available
    
    
    
15. FAVI E, Santangelo R, Iesari S, Morandi M, et al
    Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience.
    Transplant Proc. 2017;49:1766-1772.
    PubMed     Text format     Abstract available
    
    
    September 2017
16. ECHENIQUE IA, Beltran D, Ramirez-Ruiz L, Najafian N, et al
    Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report.
    Transplant Proc. 2017;49:1560-1564.
    PubMed     Text format     Abstract available
    
    
    June 2017
17. BRUMINHENT J, Rotjanapan P, Watcharananan SP
    Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.
    Transplant Proc. 2017;49:1048-1052.
    PubMed     Text format     Abstract available
    
    
    
18. HARADA S, Nakamura T, Ushigome H, Akutsu N, et al
    Beneficial Effects of High-Dose Mizoribine on ABO-Incompatible Living-Related Kidney Transplantation: Two-Year Results by a Japanese Multicenter Study.
    Transplant Proc. 2017;49:967-970.
    PubMed     Text format     Abstract available
    
    
    May 2017
19. BRASIL IRC, Custodio-Lima J, Sampaio RL, Pierre AMM, et al
    Pre-emptive Therapy for Cytomegalovirus in Post-transplantation Liver Patients With Donor-Positive/Recipient-Negative Serostatus.
    Transplant Proc. 2017;49:871-873.
    PubMed     Text format     Abstract available
    
    
    
20. PRETAGOSTINI R, Poli L, Lai Q, Russo G, et al
    Pre-Emptive Therapy for the Treatment of Cytomegalovirus After Kidney Transplantation.
    Transplant Proc. 2017;49:638-641.
    PubMed     Text format     Abstract available
    
    
    
21. PULITI REIGADA CH, de Ataide EC, de Almeida Prado Mattosinho T, Boin IFSF, et al
    Hepatic Artery Thrombosis After Liver Transplantation: Five-Year Experience at the State University of Campinas.
    Transplant Proc. 2017;49:867-870.
    PubMed     Text format     Abstract available
    
    
    April 2017
22. KIR O, Zeytinoglu A, Arda B, Yilmaz M, et al
    Impact of Prophylaxis vs Pre-emptive Approach for Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2017;49:537-540.
    PubMed     Text format     Abstract available
    
    
    March 2017
23. RUAN V, Czer LS, Awad M, Kittleson M, et al
    Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.
    Transplant Proc. 2017;49:253-259.
    PubMed     Text format     Abstract available
    
    
    January 2017
24. SHI Y, Liu H, Chen XG, Shen ZY, et al
    Comparison of Mizoribine and Mycophenolate Mofetil With a Tacrolimus-Based Immunosuppressive Regimen in Living-Donor Kidney Transplantation Recipients: A Retrospective Study in China.
    Transplant Proc. 2017;49:26-31.
    PubMed     Text format     Abstract available
    
    
    November 2016
25. LUNA E, Caravaca F, Ferreira F, Fernandez N, et al
    Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy.
    Transplant Proc. 2016;48:2931-2937.
    PubMed     Text format     Abstract available
    
    
    
26. CARBONE J, Gallego A, Fernandez Yanez J, Sousa I, et al
    Potential Immunomodulatory Role of Specific Anticytomegalovirus Intravenous Immunoglobulin in Heart Recipients.
    Transplant Proc. 2016;48:3027-3029.
    PubMed     Text format     Abstract available
    
    
    October 2016
27. FENG S, Yang J, Wang W, Hu X, et al
    Incidence and Risk Factors for Cytomegalovirus Infection in Patients With Kidney Transplantation: A Single-Center Experience.
    Transplant Proc. 2016;48:2695-2699.
    PubMed     Text format     Abstract available
    
    
    May 2016
28. MATSUURA R, Maeda A, Sakai R, Eguchi H, et al
    Human HLA-Ev (147) Expression in Transgenic Animals.
    Transplant Proc. 2016;48:1323-5.
    PubMed     Text format     Abstract available
    
    
    April 2016
29. IWAMOTO H, Nakamura Y, Konno O, Tomita K, et al
    Immunosuppressive Therapy for Elderly Kidney Transplant Recipients.
    Transplant Proc. 2016;48:799-801.
    PubMed     Text format     Abstract available
    
    
    
30. USHIGOME H, Uchida K, Nishimura K, Akioka K, et al
    Efficacy and Safety of High-Dose Mizoribine Combined With Cyclosporine, Basiliximab, and Corticosteroids in Renal Transplantation: A Japanese Multicenter Study.
    Transplant Proc. 2016;48:794-8.
    PubMed     Text format     Abstract available
    
    
    March 2016
31. ARZE S, Arze L, Abecia C
    Post-transplantation Infections in Bolivia.
    Transplant Proc. 2016;48:646-53.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: